NEOPLASMS BY SITE

Clinical trials for NEOPLASMS BY SITE explained in plain language.

Never miss a new study

Get alerted when new NEOPLASMS BY SITE trials appear

Sign up with your email to follow new studies for NEOPLASMS BY SITE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet recruiting 1 Not yet finished but already full! 6 Completed 4 Terminated 3

UK trial aims to repurpose existing drugs for rare and Hard-to-Treat cancers

Disease control Not yet recruiting

This trial is testing if two already-approved cancer drugs, dabrafenib and trametinib, can help patients with rare cancers or common cancers that have a rare, specific genetic change called a BRAF V600 mutation. The drugs are already used for some cancers like melanoma, but resea…

Matched conditions: NEOPLASMS BY SITE

Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

NEOPLASMS BY SITE

Get alerted when new NEOPLASMS BY SITE trials appear

UK trial aims to repurpose existing drugs for rare and Hard-to-Treat cancers